BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 14, 2011
 |  BC Week In Review  |  Company News  |  Other News

PDL BioPharma, UCB autoimmune news

The companies settled all legal disputes, including proceedings related to UCB's Cimzia certolizumab pegol and PDL's Queen et al. patents, which cover humanized antibodies. Under the settlement, PDL will waive its right to sue UCB for royalties on Cimzia...

Read the full 183 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >